Singapore Markets closed

PAVmed Inc. (PAVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3550-0.0093 (-2.55%)
At close: 04:00PM EDT
0.3678 +0.01 (+3.61%)
Pre-market: 08:37AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.3643
Open0.3600
Bid0.3501 x 1000
Ask0.3800 x 1000
Day's range0.3501 - 0.3698
52-week range0.3500 - 2.3400
Volume211,829
Avg. volume465,741
Market cap33.265M
Beta (5Y monthly)0.87
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    PAVmed and Lucid Diagnostics Provide Strategic Business Update

    NEW YORK, January 17, 2023--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiaries Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or "Lucid Diagnostics"), a commercial-stage cancer prevention diagnostics company, and Veris Health Inc. ("Veris"), a private digital health company focused on enhanced personalized cancer care, today provided a

  • Business Wire

    PAVmed and Lucid Diagnostics to Provide Strategic Business Update

    NEW YORK, January 11, 2023--Companies will present refinements to their business strategy as each continue to the benefit patients in need and create value for shareholders.

  • Business Wire

    PAVmed Partners with Novosound on Ultrasound Imaging Technology

    NEW YORK, December 22, 2022--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it has entered into a license option and joint research and development agreement with Novosound Ltd. ("Novosound"), a venture-backed technology company based in Glasgow, Scotland, to explore applying Novosound’s proprietary flexible thin-film ultrasound technology in me